A message from our CEO,
Alexis Dormandy

Oxford Sciences Innovation (OSI) was founded in 2015 with a big ambition; to create a world where the best scientists and brightest business minds combine to solve the world’s biggest challenges at unprecedented speed.

Since 2015, our partnership with Oxford University has led to a share in more than 100 Oxford science spinouts, founded by over 200 of Oxford’s leading academics, whose value is now worth over £2bn – and we have taken a leading role in creating and building over 70 of these, creating +2,000 jobs and adding +55,000 sq ft of lab & start-up space to support them.

Together with Oxford University we have helped to create a phenomenal science-business ecosystem:

  • Increasing university spinouts from an average of 5 companies per year to over 20
  • Increasing investment in university spinouts from an average of £125m per year (2011-2015) to £600m (2016 – 2021)
  • Attracting an incredible influx of scientific and management talent from around the world

Our businesses are now making a remarkable impact on the world, from the Oxford vaccine that is supplied around the world (and represents 98% of COVAX vaccines), to Base Genomics, acquired by Exact Sciences for its revolutionary early-stage cancer detection technology, to breakthroughs in fusion, electric motors, quantum, and AI diagnostics for heart disease.

Six years ago, OSI was just an idea. One year ago, OSI was a start-up celebrating its 5th birthday. Today OSI has entered the next phase of its journey – an ambitious business that recently passed its £1bn valuation. The team past and present, should feel incredibly proud of what they have achieved, in such a short space of time – it is truly amazing.

I joined OSI in January 2021, clear on its mission, inspired by its achievements, and motivated by the opportunity to make a real difference to the world. Since then, an enormous amount of work has taken place behind the scenes:

  • We have expanded the team including new leads for the Life Science, Technology, and Late Stage sides of the business, in Katya Smirnyagina, Alexis Zervoglos, and Ceri Morgan
  • We have refined and evolved our approach to business creation, business scaling and investment; creating a systematic and scalable method to source and support high quality start-ups
  • We have defined a new set of values to guide us, ensuring we act in a way that we will be proud of twenty years from now

As we continue to grow and evolve as a business, being clear about our vision, purpose, and values – and our focus on building social and economic value – is critical.

We are a company, not a fund – and this makes us unique. We partner the best scientists from the world’s best university with the best business brains, we work hard to maximise the impact of Oxford’s science, and then we reinvest the returns made as result of that impact back into Oxford’s scientific research and the next generation of world-changing businesses – creating a virtuous and sustainable loop.

We are Science Business Builders.

And to reflect more clearly who and what we are, we have chosen to rebrand.

We are excited to now be starting the next chapter in our story, as Oxford Science Enterprises.


Stay up to date

Get the latest on cutting edge developments from our enterprises straight to your inbox